AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹259 Cr | ₹131 Cr | ₹85 Cr | ₹73 Cr | - |
What is the latest Total Non-Current Liabilities ratio of AARTI PHARMALABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹259 Cr |
| Mar2024 | ₹131 Cr |
| Mar2023 | ₹85 Cr |
| Mar2022 | ₹73 Cr |
| Mar2021 | - |
How is Total Non-Current Liabilities of AARTI PHARMALABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹259 Cr | 98.54 | |
| Mar2024 | ₹131 Cr | 53.89 | |
| Mar2023 | ₹85 Cr | 16.71 | |
| Mar2022 | ₹73 Cr | 0 | |
| Mar2021 | - | - | |
Compare Total Non-Current Liabilities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹6,977.1 Cr | -8.8% | -7.7% | 15.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,738.0 Cr | 1.4% | 3.5% | -5.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,460.0 Cr | -3.9% | 6.6% | 15.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,476.0 Cr | 7% | 7.8% | 19.8% | Stock Analytics | |
| CIPLA | ₹122,361.0 Cr | 0.8% | 0.2% | -5.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,101.0 Cr | 0.9% | -2.8% | -5.8% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | -8.8% |
-7.7% |
15.4% |
| SENSEX | -0.1% |
2.6% |
6.5% |
You may also like the below Video Courses